An interventional study of Negative Pleural Suction at -20 cm H2O and Water seal in Hemothorax, Pneumothorax and Hemopneumothorax, sponsored by Universidad de Antioquia. Completed at 1 site in Colombia. Open to participants aged 15 Years and older. Per ClinicalTrials.gov, last updated 2013-05-29.
Sponsored by Universidad de Antioquia · Not applicable, Interventional, and Treatment
The purpose of this study is to determine whether the use of negative pleural suction in tube thoracostomy is more effective than water seal alone for the treatment of pneumothorax and/or hemothorax in patients with chest trauma.
26 studies on the registry are indexed under Hemothorax; 5 are open to participants now.
This study's enrollment of 110 is close to the median of 100 across 21 interventional studies indexed under Hemothorax.
Browse Hemothorax studies →Universidad de Antioquia is the lead sponsor of 80 studies on the registry; 9 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients are put on negative pleural suction at - 20 cm H2O
Other: Negative Pleural Suction at -20 cm H2O · Other: Water seal
Patients al left on water seal only
Other: Water seal
Lenght of Hospital stay
Time frame: 30 days
Incidence of persistent bronchopleural fistulae
Time frame: 30 days
Incidence of coagulated Hemothorax
Time frame: 30 days
Incidence of empyema
Time frame: 30 days
Incidence of recurrent pneumothorax
Time frame: 30 days
Number of patients necessitating surgical interventions (includes new thoracostomy, thoracoscopy and open thoracotomy)
Time frame: 30 days
The record gives a start of Mar 2012, a primary completion of Nov 2012 and a completion of Nov 2012. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in May 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universidad de Antioquia